FPH2 (BRD-9424)
|
F418549-50mg
|
≥98% |
957485-64-2 |
50mg
|
¥ 2839.9
|
现货 |
阿拉丁 |
FPH2 (BRD-9424)
|
F418549-2mg
|
≥98% |
957485-64-2 |
2mg
|
¥ 289.9
|
现货 |
阿拉丁 |
FPH2 (BRD-9424)
|
F418549-25mg
|
≥98% |
957485-64-2 |
25mg
|
¥ 1629.9
|
现货 |
阿拉丁 |
FPH2 (BRD-9424)
|
F418549-10mg
|
≥98% |
957485-64-2 |
10mg
|
¥ 699.9
|
现货 |
阿拉丁 |
FPH2 (BRD-9424)
|
F418549-100mg
|
≥98% |
957485-64-2 |
100mg
|
¥ 5179.9
|
现货 |
阿拉丁 |
非戈替尼(GLPG0634)
|
F413789-250mg
|
Moligand™, ≥98% |
1206161-97-8 |
250mg
|
¥ 898.9
|
现货 |
阿拉丁 |
非戈替尼(GLPG0634)
|
F413789-1g
|
Moligand™, ≥98% |
1206161-97-8 |
1g
|
¥ 2338.9
|
现货 |
阿拉丁 |
氟苯吡菌胺
|
F412925-5mg
|
≥98% |
907204-31-3 |
5mg
|
¥ 1013.9
|
现货 |
阿拉丁 |
氟苯吡菌胺
|
F412925-50mg
|
≥98% |
907204-31-3 |
50mg
|
¥ 5668.9
|
现货 |
阿拉丁 |
氟苯吡菌胺
|
F412925-10mg
|
≥98% |
907204-31-3 |
10mg
|
¥ 1618.9
|
现货 |
阿拉丁 |
氟苯吡菌胺
|
F412925-100mg
|
≥98% |
907204-31-3 |
100mg
|
¥ 8910.9
|
现货 |
阿拉丁 |
Fmoc-Val-Cit-PAB-PNP
|
F404474-5g
|
≥98% |
863971-53-3 |
5g
|
¥ 4996.9
|
现货 |
阿拉丁 |
Fmoc-Val-Cit-PAB-PNP
|
F404474-250mg
|
≥98% |
863971-53-3 |
250mg
|
¥ 646.9
|
现货 |
阿拉丁 |
2'-氟-5'-甲基苯乙酮
|
F338194-5g
|
≥97% |
446-07-1 |
5g
|
¥ 362.9
|
现货 |
阿拉丁 |
2'-氟-5'-甲基苯乙酮
|
F338194-25g
|
≥97% |
446-07-1 |
25g
|
¥ 1600.9
|
现货 |
阿拉丁 |
五水亚叶酸钙
|
F304111-5g
|
≥99% |
6035-45-6 |
5g
|
¥ 159.9
|
现货 |
阿拉丁 |
五水亚叶酸钙
|
F304111-25g
|
≥99% |
6035-45-6 |
25g
|
¥ 729.9
|
现货 |
阿拉丁 |
五水亚叶酸钙
|
F304111-1g
|
≥99% |
6035-45-6 |
1g
|
¥ 39.9
|
现货 |
阿拉丁 |
FTIDC,mGlu1受体的负变构调节剂
|
F288677-5mg
|
Moligand™, ≥98%(HPLC) |
873551-53-2 |
5mg
|
¥ 2319.9
|
现货 |
阿拉丁 |
FTIDC,mGlu1受体的负变构调节剂
|
F288677-50mg
|
Moligand™, ≥98%(HPLC) |
873551-53-2 |
50mg
|
¥ 9999.9
|
现货 |
阿拉丁 |
FTIDC,mGlu1受体的负变构调节剂
|
F288677-25mg
|
Moligand™, ≥98%(HPLC) |
873551-53-2 |
25mg
|
¥ 6999.9
|
现货 |
阿拉丁 |
FMF-04-159-2,共价CDK14和CDK16抑制剂
|
F288523-5mg
|
≥98%(HPLC) |
2364489-81-4 |
5mg
|
¥ 949.9
|
期货,请咨询 |
阿拉丁 |
FMF-04-159-2,共价CDK14和CDK16抑制剂
|
F288523-50mg
|
≥98%(HPLC) |
2364489-81-4 |
50mg
|
¥ 6159.9
|
期货,请咨询 |
阿拉丁 |
FMF-04-159-2,共价CDK14和CDK16抑制剂
|
F288523-25mg
|
≥98%(HPLC) |
2364489-81-4 |
25mg
|
¥ 3419.9
|
期货,请咨询 |
阿拉丁 |